Cancer-Specific Delivery of Proteolysis-Targeting Chimeras (PROTACs) and Their Application to Cancer Immunotherapy
Proteolysis-targeting chimeras (PROTACs) are rapidly emerging as a potential therapeutic strategy for cancer therapy by inducing the degradation of tumor-overexpressing oncogenic proteins. They can specifically catalyze the degradation of target oncogenic proteins by recruiting E3 ligases and utiliz...
Zapisane w:
| Główni autorzy: | , , , |
|---|---|
| Format: | Artigo |
| Język: | Inglês |
| Wydane: |
MDPI AG
2023-01-01
|
| Seria: | Pharmaceutics |
| Hasła przedmiotowe: | |
| Dostęp online: | https://www.mdpi.com/1999-4923/15/2/411 |
| Etykiety: |
Nie ma etykietki, Dołącz pierwszą etykiete!
|